These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1006 related items for PubMed ID: 12810676

  • 41. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 42. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.
    Cold Spring Harb Symp Quant Biol; 2005 Mar 02; 70():129-37. PubMed ID: 16869746
    [Abstract] [Full Text] [Related]

  • 43. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P, Agarwal P, Bird RC.
    J Cell Biochem; 2009 Feb 15; 106(3):491-505. PubMed ID: 19130492
    [Abstract] [Full Text] [Related]

  • 44. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG, Normand G, Verdoodt B, von Haefen C, Hasenjäger A, Güner D, Wendt J, Dörken B, Daniel PT.
    Oncogene; 2005 Jun 09; 24(25):4114-28. PubMed ID: 15750619
    [Abstract] [Full Text] [Related]

  • 45. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 09; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 46. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 47. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW, Lou SQ, Zhang K.
    Rheumatology (Oxford); 2004 May 22; 43(5):555-68. PubMed ID: 15026580
    [Abstract] [Full Text] [Related]

  • 48. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO, Samuel T, Rauch P, Funk JO.
    Oncogene; 2002 May 09; 21(20):3207-12. PubMed ID: 12082636
    [Abstract] [Full Text] [Related]

  • 49. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I, Benet M, Jiménez M, Alzabin S, Malumbres M, Pellicer A.
    Cancer Res; 2005 Apr 15; 65(8):3249-56. PubMed ID: 15833857
    [Abstract] [Full Text] [Related]

  • 50. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC, Klimstra DS, Varmus HE.
    Genes Dev; 2003 Dec 15; 17(24):3127-38. PubMed ID: 14681205
    [Abstract] [Full Text] [Related]

  • 51. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA.
    Nat Cell Biol; 2007 May 15; 9(5):493-505. PubMed ID: 17450133
    [Abstract] [Full Text] [Related]

  • 52. A novel highly informative polyA microsatellite on the telomeric side of the INK4a/ARF locus.
    Chaubert P, Burri N, Cousin P, Shaw P.
    Mol Cell Probes; 2001 Jun 15; 15(3):183-5. PubMed ID: 11352600
    [Abstract] [Full Text] [Related]

  • 53. p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
    Sharpless NE, Alson S, Chan S, Silver DP, Castrillon DH, DePinho RA.
    Cancer Res; 2002 May 15; 62(10):2761-5. PubMed ID: 12019151
    [Abstract] [Full Text] [Related]

  • 54. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
    Zhang Z, Wang Y, Yao R, Li J, Yan Y, La Regina M, Lemon WL, Grubbs CJ, Lubet RA, You M.
    Oncogene; 2004 May 06; 23(21):3841-50. PubMed ID: 15021904
    [Abstract] [Full Text] [Related]

  • 55. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M, Hernández L, Martínez A, Cobo F, Hernández S, Beà S, López-Guillermo A, Nayach I, Palacín A, Nadal A, Fernández PL, Montserrat E, Cardesa A, Campo E.
    Am J Pathol; 2000 Jun 06; 156(6):1987-96. PubMed ID: 10854221
    [Abstract] [Full Text] [Related]

  • 56. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 57. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J, Lee RJ, Li Z, Wang C, Katiyar S, Yang J, Quong AA, Wu K, Albanese C, Russell R, Di Vizio D, Koff A, Thummala S, Zhang H, Harrell J, Sun H, Muller WJ, Inghirami G, Lisanti MP, Pestell RG.
    Cancer Res; 2006 Sep 01; 66(17):8529-41. PubMed ID: 16951165
    [Abstract] [Full Text] [Related]

  • 58. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
    Sung YH, Park J, Choi B, Kim J, Cheong C, Choi YS, Yang EY, Lee M, Han JS, Park SC, Han TH, Kim TJ, Song J, Rhee K, Lee HW.
    Mech Ageing Dev; 2005 Sep 01; 126(6-7):732-9. PubMed ID: 15888328
    [Abstract] [Full Text] [Related]

  • 59. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ.
    Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828
    [Abstract] [Full Text] [Related]

  • 60. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.